Bilateral acute depigmentation of the iris

disease
On this page

Also known as BADI

Summary

Bilateral acute depigmentation of the iris (MONDO:0019074) is a disease. A subtype of iridogoniodysgenesis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
  • Phenotypes (HPO): 10

Clinical features

Epidemiology

Prevalence records

2 prevalence record(s), Orphanet:

TypeClassValueGeographyValidation
Cases/families62WorldwideValidated
Point prevalence<1 / 1 000 000WorldwideValidated

Signs & symptoms

Clinical features (HPO)

10 HPO clinical features (Orphanet curated; top 10 by frequency):

HPO IDTermFrequency
HP:0007990Hypoplastic iris stromaObligate (100%)
HP:0008034Abnormal iris pigmentationObligate (100%)
HP:0000593Abnormal anterior chamber morphologyFrequent (30-79%)
HP:0000613PhotophobiaFrequent (30-79%)
HP:0011488Abnormal corneal endothelium morphologyFrequent (30-79%)
HP:0012372Abnormal eye morphologyFrequent (30-79%)
HP:0200026Ocular painFrequent (30-79%)
HP:0002788Recurrent upper respiratory tract infectionsOccasional (5-29%)
HP:0012631Pigment deposition in the trabecular meshworkOccasional (5-29%)
HP:0012634Iris pigment dispersionOccasional (5-29%)

Identifiers

Disease identifiers

FieldValue
Canonical namebilateral acute depigmentation of the iris
Mondo IDMONDO:0019074
Orphanet69736
SNOMED CT720460007
UMLSC4304058
MedGen929727
GARD0018897
Is cancer (heuristic)no

Also known as: BADI

Disease family

Classification path: disease › human disease › disease by etiologic mechanism › disease of genetic or genomic mechanism › hereditary diseaseanterior segment dysgenesis › iridogoniodysgenesis › bilateral acute depigmentation of the iris

Related subtypes (6): congenital microcoria, aniridia-cerebellar ataxia-intellectual disability syndrome, chromosome 6pter-p24 deletion syndrome, Rieger anomaly, congenital ectropion uveae, FOXC1-related anterior segment dysgenesis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.